+48.2%
GSK vs NYT
+38.8%
+9.4%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | NYT | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.5% | -0.4% | 0.0% |
| 7D | -3.5% | -0.6% | -2.9% | -3.5% |
| 30D | -3.4% | +4.6% | -8.0% | -3.6% |
| 3M | -8.1% | -9.6% | +1.5% | -7.8% |
| 6M | -11.1% | -14.0% | +2.9% | -10.8% |
| YTD | +0.7% | -2.8% | +3.6% | +0.8% |
| 1Y | +20.1% | +15.6% | +4.5% | +19.6% |
| 3Y | +46.1% | +56.3% | -10.2% | +42.5% |
| All | +48.2% | +38.8% | +9.4% | +35.8% |
Cumulative growth
Daily Returns
Daily percentage return beside NYT.
Daily Out/Under-Performance
Portfolio return minus NYT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NYT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded NYT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling